The changing epidemiology of septic arthritis in children.
D000293:Adolescent; D000367:Age Factors; D000667:Ampicillin / Q000627:therapeutic use; D001170:Arthritis, Infectious / Q000150:complications / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D002648:Child; D002675:Child, Preschool; D004927:Escherichia coli Infections / Q000150:complications; D005260:Female; D006192:Haemophilus Infections / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D006193:Haemophilus influenzae / Q000302:isolation & purification; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007612:Kanamycin / Q000627:therapeutic use; D008297:Male; D008583:Meningitis, Haemophilus / Q000150:complications*; D008589:Meningococcal Infections / Q000150:complications; D008712:Methicillin / Q000627:therapeutic use; D011008:Pneumococcal Infections / Q000150:complications; D011552:Pseudomonas Infections / Q000150:complications; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D013203:Staphylococcal Infections / Q000150:complications; D013290:Streptococcal Infections / Q000150:complications
D007612:Kanamycin; D000667:Ampicillin; D008712:Methicillin